Canadian computer-aided detection (CAD) software developer Medipattern of Toronto has received a medical device license from Health Canada for its B-CAD for breast ultrasound application.
The approval, along with recent European CE Mark and U.S. FDA clearances, allows the product to be sold virtually worldwide, according to the company. B-CAD for ultrasound is available as Cedara B-CAD through Merge Healthcare of Milwaukee's Cedara Software subsidiary.
By AuntMinnie.com staff writers
December 6, 2005
Related Reading
Medipattern unveils CAD for breast MRI at RSNA show, November 28, 2005
Cedara B-CAD nets FDA clearance, June 2, 2005
Cedara, Medipattern team up, August 17, 2004
Copyright © 2005 AuntMinnie.com
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
